Skip to content

The application of ultrasound localization microscopy in pancreatic diseases

The application of ultrasound localization microscopy in pancreatic diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114469
Enrollment
Unknown
Registered
2025-12-12
Start date
2025-12-20
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas disease

Interventions

Index test:Ultrasound localization microcirculation imaging: 1. qualitative parameters

Sponsors

General Hospital of the People's Liberation Army of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age>=18 years. 2.Patients scheduled to undergo contrast-enhanced ultrasound of the pancreas at our hospital due to clinical suspicion of a pancreatic space-occupying lesion. 3.Voluntary participation in this study and provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1.Presence of contraindications to ultrasound contrast agents (e.g., allergy to sulfur hexafluoride, severe cardiopulmonary insufficiency, right-to-left cardiac shunt). 2.Pregnancy or lactation. 3.Inability to cooperate and complete the ultrasound examination (e.g., due to severe dyspnea). (4) Having received any treatment for the suspected pancreatic lesion prior to enrollment. (5) Unclear diagnosis after evaluation.

Design outcomes

Primary

MeasureTime frame
Diagnostic performances of qualitative parameters(Density pattern);Diagnostic performances of quantitative parameters(vessel ratio,density,velocity,perfusion,et al);

Secondary

MeasureTime frame
The differences in the quantitative parameters for the differential diagnosis(vessel ratio,density,velocity,perfusion,et al);The differences in the qualitative parameters for the differential diagnosis(Density pattern);Relationships between the quantitative parameters and histologic biomarkers;The evaluation of inter-reader and intra-reader reproducibility;

Countries

China

Contacts

Public ContactZhang Mingbo

General Hospital of the People's Liberation Army of China

owsifanduizhe@126.com+86 135 5274 4805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026